Prashant Raghavan PhD
About Prashant Raghavan PhD
Prashant Raghavan, PhD, serves as the Executive Director of Competitive Intelligence and Corporate Strategy at Sana Biotechnology, Inc. He has held various roles in the biotechnology and consulting sectors, including positions at Shire and Bain & Company.
Current Role at Sana Biotechnology
Prashant Raghavan serves as the Executive Director of Competitive Intelligence and Corporate Strategy at Sana Biotechnology, Inc. He has held this position since 2019, contributing to the company's strategic initiatives and competitive analysis in the biotechnology sector. His role involves overseeing the development and implementation of strategies that align with Sana's mission to create transformative cell-based therapies.
Previous Experience at Shire
Prior to his current role, Raghavan worked at Shire as the Director of R&D Business Analytics Decision Support Lead from 2015 to 2018. In this capacity, he was responsible for providing analytical support to research and development initiatives, enhancing decision-making processes within the organization. His tenure at Shire was based in Lexington, MA.
Experience at Juno Therapeutics
Raghavan had two roles at Juno Therapeutics, Inc. in 2018. He first served as the Director of Finance, Finance and Accounting for four months, followed by a position as Director of CMC Lifecycle Management for five months. His work focused on financial oversight and lifecycle management within the organization, contributing to Juno's operational efficiency.
Educational Background
Raghavan's educational journey includes a Bachelor of Science (BSc) and a Master of Science (MSc) in Biochemistry from Delhi University. He furthered his studies at Baylor College of Medicine, where he earned a PhD in Molecular and Cellular Biology. His foundational education was completed at Don Bosco, Delhi, and Delhi Public School, RK Puram.
Experience at Bain & Company and Harvard Medical School
Before his roles in the biotechnology industry, Raghavan worked as a Management Consultant at Bain & Company from 2011 to 2014 in Boston. He also served as a Postdoctoral Fellow at Harvard Medical School from 2009 to 2011, where he engaged in advanced research, contributing to his expertise in the life sciences.